这起事件导致Kellogg公司计提7000万美元的成本费用,品牌形象和信誉也受到严重损害。如果Kellogg能够严格执行FDA对食品生产环境和污染物的标准,就不会发生这种情况。引用网址：https://www.foodsafetynews.com/2010/06/kelloggs-recalls-some-popular-cereals/ 另一个例子是2011年, 著名汉堡连锁品牌Burger King被迫从美国和...
When you turn on the TV at night, chances are you will see one or more commercials discussing the recall of a prescription drug. While most people may ignore these commercials, the reality is that prescription drug recalls are not uncommon. However, many people are unaware of the actual ...
https://www.fda.gov/food/importing-food-products-united-states/fda-strategy-safety-imported-food FDA Drug Recalls Report (2022) - https://www.fda.gov/drugs/drug-safety-and-availability/drug-recalls
Recalled Diamond Shruumz brand micro-dosing chocolate bars, cones and gummies.U.S. Food and Drug Administration Prophet Premium Blends on May 27, 2024, received two complaints of people becoming ill after eating an entire chocolate bar, prompting the company to review an analysis of its ingredie...
The recall comes years after surgeons say they first noticed problems with the HeartMate II and HeartMate 3, manufactured by Thoratec Corp., a subsidiary of Abbott Laboratories.
FDA. (2023, March 1). FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan). Retrieved fromhttps://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-angiotensin-ii-receptor-blocker-arb-recalls-val...
doi:10.1093/ajhp/48.12.2595Crawford Stephanie YAmerican Journal of Hospital Pharmacy
The FDA is expected to decide as early as this week whether the recreational drug will be allowed for medical use nationwide. Josh Fiallo | Published Aug 05, 2024 FDA Approves Second Alzheimer’s Drug after Promising TrialTreatment Hope “Kisunla” will be marketed by Eli Lilly, which also ...
Custom Device Exemption: Guidance for Industry and Food and Drug Administration Staff Distinguishing Medical Device Recalls from Medical Device Enhancements: Guidance for Industry and Food and Drug Administration Staff Molecular Diagnostic Instruments with Combined Functions: Guidance for Industry and Food and...
October 2, 2024 -- The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved. Tirzepatide injection has been in shortage since 2022 due to increased demand. ...